🔎 Trials Near Me

Home › B-Cell Lymphoma

B-Cell Lymphoma clinical trials recruiting in the U.S.

68 studies for B-Cell Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT05272384

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT05370430

A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07735533

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07101328

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07188558

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07520006

A Study of ARC-02 in B-cell NHL

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07691606

Family Study of Lymphoproliferative Disorders

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Nov 2, 2026 · NCT00626496

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Oct 29, 2026 · NCT06131801

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06564038

GLORY: Glofit-GemOx With Liso-Cel For Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07711483

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT07532525

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06528301

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06526793

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Recruiting
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05940272

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT06026319

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.